{
    "2018-04-20": [
        [
            {
                "time": "2018-04-17",
                "original_text": "Blue-Chip Stocks to Buy Ahead of Eye-Popping Earnings",
                "features": {
                    "keywords": [
                        "Blue-Chip",
                        "Buy",
                        "Earnings"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-23",
                "original_text": "J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?",
                "features": {
                    "keywords": [
                        "J&J",
                        "Novartis",
                        "Q1",
                        "Earnings",
                        "Impress"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-25",
                "original_text": "Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR",
                "features": {
                    "keywords": [
                        "Pharma",
                        "NVS",
                        "JNJ",
                        "Q1",
                        "Sales",
                        "Earnings",
                        "MRK",
                        "BMY",
                        "AACR"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-26",
                "original_text": "Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress",
                "features": {
                    "keywords": [
                        "Dow",
                        "AmEx",
                        "Goldman",
                        "IBM",
                        "JNJ",
                        "P&G",
                        "UNH",
                        "Earnings",
                        "Impress"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "technology",
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-27",
                "original_text": "J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?",
                "features": {
                    "keywords": [
                        "J&J",
                        "Novartis",
                        "Q1",
                        "Earnings",
                        "Impress"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-30",
                "original_text": "AbbVie And Other Great Pharma And Biotech Income Stocks",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Pharma",
                        "Biotech",
                        "Income",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Johnson & Johnson is betting on vision care and expanding beyond contacts",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "vision",
                        "care",
                        "expanding",
                        "contacts"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}